Key statistics
As of last trade Trevi Therapeutics Inc (TRVI:NMQ) traded at 12.40, -13.83% below its 52-week high of 14.39, set on Dec 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 12.12 |
|---|---|
| High | 12.55 |
| Low | 11.92 |
| Bid | 12.39 |
| Offer | 12.40 |
| Previous close | 12.57 |
| Average volume | 1.24m |
|---|---|
| Shares outstanding | 128.23m |
| Free float | 127.34m |
| P/E (TTM) | -- |
| Market cap | 1.61bn USD |
| EPS (TTM) | -0.3713 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 19:56 GMT.
More ▼
- Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)
- Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference
- Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
